DaVita Statement on Government's Kidney Care Choices (KCC) Model Updates

Rhea-AI Summary

DaVita (DVA) announced that the Center for Medicare and Medicaid Innovation (CMMI) has extended its Kidney Care Choices (KCC) Model for an additional year. The company, a leading kidney care provider, has expanded its value-based care arrangements from 11 Kidney Contracting Entities (KCEs) in 2022 to 22 KCEs currently. Recent reports show these arrangements have improved patient outcomes, including increased transplantation rates, more optimal dialysis access placement, and higher home dialysis adoption. DaVita serves approximately 282,000 patients across 3,173 outpatient dialysis centers globally, with 2,661 centers in the United States and 512 centers in 13 other countries as of March 31, 2025.

Positive

• Extension of the Kidney Care Choices Model indicates program success and government support
• Doubled value-based care arrangements from 11 to 22 Kidney Contracting Entities
• Improved patient outcomes including increased transplantation and home dialysis rates
• Large established presence with 3,173 outpatient dialysis centers serving 282,000 patients globally

Negative

• None.

DENVER, May 30, 2025 /PRNewswire/ -- DaVita, a comprehensive kidney care company, issued the following statement in response to updates this week from the Center for Medicare and Medicaid Innovation (CMMI) related to its Kidney Care Choices (KCC) Model. It can be attributed to Misha Palecek, chief transformation officer for DaVita.

"As a dedicated participant in the government's value-based care initiative and a pioneer in this field for the last twenty years, we applaud CMMI's decision to extend the Kidney Care Choices (KCC) Model for an additional year. We believe the investments made by CMMI and participants alike will result in long-term savings in the upcoming years. The program's emphasis on comprehensive, collaborative care and patient engagement is driving encouraging health outcomes. DaVita is committed to establishing a new standard for kidney care through integrated care systems alongside our nephrology partners."

Together with participating nephrologists, DaVita launched 11 value-based care arrangements in 2022 and has since doubled that footprint to 22 Kidney Contracting Entities (KCEs). A recent report demonstrates that these value-based care arrangements result in increased transplantation, more patients dialyzing with an optimal access in place, and more patients dialyzing at home.

To learn more about DaVita Integrated Kidney Care programs, visit DaVita.com/Innovation.

About DaVita Inc.
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for 25 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of March 31, 2025, DaVita served approximately 282,000 patients at 3,173 outpatient dialysis centers, of which 2,661 centers were located in the United States and 512 centers were located in 13 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, helped improve health access and worked collaboratively to propel the kidney care community to adopt a higher quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.

Media Contact

Newsroom@davita.com

View original content:https://www.prnewswire.com/news-releases/davita-statement-on-governments-kidney-care-choices-kcc-model-updates-302469731.html

SOURCE DaVita

FAQ

What is the Kidney Care Choices (KCC) Model extension announced by DaVita (DVA)?

CMMI has extended the Kidney Care Choices Model for an additional year, supporting DaVita's value-based care initiatives in kidney care.

How many Kidney Contracting Entities (KCEs) does DaVita currently operate?

DaVita has expanded from 11 KCEs in 2022 to 22 Kidney Contracting Entities currently.

What improvements has DaVita reported in their value-based care arrangements?

DaVita reported increased transplantation rates, more patients dialyzing with optimal access, and more patients dialyzing at home.

How many dialysis centers does DaVita operate as of March 2025?

DaVita operates 3,173 outpatient dialysis centers, with 2,661 in the United States and 512 centers across 13 other countries.

How many patients does DaVita serve globally?

As of March 31, 2025, DaVita served approximately 282,000 patients globally.